News
-
-
PRESS RELEASE
Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
Xlife Sciences AG reports strong portfolio growth and strategic advances in the 2023 Valuation Report by independent consulting firm CYLAD Experts. Portfolio valued at CHF 611.7-747.8 million -
-
-
PRESS RELEASE
Straumann Group showed a solid start into 2024, with varied regional growth dynamic
Straumann Group reports strong organic revenue growth of 15.1% in the first quarter of 2024, reaching CHF 643.8 million. Regional dynamics vary, with Asia Pacific leading. New premium implant system and intraoral scanner launched -
-
-
-
-
PRESS RELEASE
Leclanché SA annonce l'extension du délai de publication du rapport annuel 2023 et publie ses chiffres clés 2023 non audités.
Leclanché SA annonce l'extension du délai de publication du rapport annuel 2023 et publie ses chiffres clés 2023 non audités. Décision approuvée par SIX Exchange Regulation SA